ArticleWiener klinische Wochenschrift2026
Short-term clinical, functional and MRI findings after hamstring allograft vs. autograft ACL reconstruction : A pilot randomized controlled trial.
Article in Wiener klinische Wochenschrift, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeGraft choice in primary anterior cruciate ligament (ACL) reconstruction remains controversial. While hamstring autografts are common, allografts offer advantages such as no donor site morbidity and reduced operation time. This study aimed to compare the clinical, functional and health-related quality of life (HRQOL) outcomes of hamstring allografts vs. autografts in primary ACL reconstruction.
methodsIn this single-center randomized controlled trial, patients undergoing primary ACL reconstruction were randomized to receive either a hamstring allograft or autograft. Clinical evaluation and patient-reported outcome measures (PROMs), including the International Knee Documentation Committee (IKDC), Knee Injury and Osteoarthritis Outcome Score (KOOS), and Short Form (SF)-36 Health survey, were collected preoperatively and at multiple follow-ups to 12 months. Operation time and postoperative magnetic resonance imaging (MRI) scans at 12 months were also analyzed.
resultsThe final cohort included 25 patients (13 allograft, 12 autograft). At 12 months, no statistically significant differences between groups were detected for any PROM. Mean IKDC scores were 83.0 ± 7.2 in the allograft group and 87.2 ± 5.0 in the autograft group (p = 0.12). Both groups demonstrated improvement in patient-reported functional outcomes; however, objective instrumented laxity testing was not performed. Mean operation time was significantly shorter for the allograft group (61.6 ± 11.4 min) compared to the autograft group (83.0 ± 13.6 min; p < 0.001).
conclusionIn this small pilot randomized cohort of patients aged 27 years and older, no statistically significant short-term differences in PROMs were detected between hamstring allograft and autograft ACL reconstruction at 12 months. Allograft use was associated with significantly shorter operative time. These findings should be interpreted cautiously because the study was not powered to demonstrate equivalence or noninferiority and longer term follow-up with objective laxity testing is required to assess graft durability and stability.
Indexed as
Identifiers
42678533What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.